New MRI dye could spot hidden prostate tumors
NCT ID NCT04286386
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 21 times
Summary
This study is testing whether a special contrast agent, called hyperpolarized 13-C pyruvate, can help MRI scanners find prostate cancer more clearly. About 130 men with prostate cancer will receive this contrast before an MRI. The goal is to see if this method improves detection of tumors that standard scans might miss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.